Miscarriage is a common complication during early pregnancy, it has been estimated that approximately 12%-15% of women have experienced a miscarriage. 1 The etiology of miscarriage varies but the most common cause of miscarriage is chromosomal abnormalities of the fetus.
Expectant management is usually chosen for uncomplicated complete spontaneous miscarriage, whereas misoprostol with or without mifepristone or surgical treatment, mainly with vacuum aspiration, is more commonly used for missed miscarriages. 5 However, the women are not prepared for the duration of the miscarriage process, which makes it even more demanding. 6, 7 Miscarriage is a stressful event; several negative emotional feelings are common such as grief, shock, isolation, loneliness, loss, devastation, guilt, and denial. 8, 9 In the present study, three different questionnaires were used to measure experiences, depressive symptoms, and grief. To measure experiences of miscarriage, the Revised Impact of Miscarriage Scale (RIMS), was used. RIMS is a scale that is used to measure experiences after miscarriage in women and men, developed from the Impact of Miscarriage Scale and originally constructed to capture the significance and meaning of miscarriage. 9 The scale was recently validated for Swedish conditions. 10 Depressive symptoms can be measured by using the Montgomery and Åsberg Depression Rating Scale (MADRS-S).
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MADRS-S was originally developed in Sweden and the UK but has been used in several countries for both women and men. Grief can also occur after miscarriage, which is measured using the Perinatal Grief Scale (PGS), originally developed to investigate perinatal loss. 12 However, little is known about how the chosen treatment of miscarriage influences psychological well-being. One recent study showed no relation in psychological outcome such as psychological well-being, depression, anxiety, or fatigue related to any of the three treatments of miscarriage, expectant management, surgical treatment, or medical treatment. The only difference noticed was reaction to treatment measured with the Chinese version of Impact of event scale-revised, where the active treatments had significantly higher scores than after medical treatment. 13 However, there is still a lack of information on how the cause, treatment management, and duration of treatment of miscarriage might influence the experience and psychological well-being after miscarriage. Therefore, the aim of this study was to determine if experience, depressive symptoms, or grief is influenced by the cause of miscarriage and type or duration of treatment. This study was a randomized, prospective, longitudinal cohort study, the women were randomly asked for voluntary participation in the study by a midwife (CJ), while attending the clinic for a follow-up visit. The participants were asked to fill out the questionnaire 1 week after finalized treatment of miscarriage. Finalized treatment was defined as no remains of the pregnancy left in the uterus and no bleeding. The participants included in the study group were asked to participate on the days the midwife was present at the clinic, usually once a week. Patients coming to the clinic on days the midwife was not present were not asked to participate in the study. Women who called but did not come to the clinic were not asked to participate in the study.
| MATERIAL AND ME THODS
All included women had experienced a miscarriage up to 21 weeks + 6 days of pregnancy and were able to understand written and spoken Swedish. The gestational age was determined from the first day of the woman's last menstrual period. The women were divided into 2 groups: spontaneous miscarriage was defined as complete or incomplete nonviable pregnancy before week 22 of gestation. Missed miscarriage was defined as the presence of a fetus without heart activity after 6 weeks of pregnancy, or anem- 
Key message
Diagnosis of miscarriage has limited influence on the experience of miscarriage; more important is the duration of treatment. Therefore, faster treatment options might be beneficial, particularly for women with missed mis carriage.
depression, 20-34 points, indicating moderate depression, and > 34 points, indicating severe depression. The PGS short version includes 33 questions with responses "strongly agree," "agree," "either disagree or agree," "disagree," and "strongly disagree," and divided into three subscales: "active grief," "difficult coping," and "despair."
| Statistical analyses
Statistical analysis was performed using IBM SPSS StatiSticS version 20.0 software (SPSS Inc, Chicago, IL) and SigmaPlot (Systat software, San Jose, CA). Mann-Whitney U test, Student's t test and
Wilcoxon's signed rank test were used for the 3 different scales and Fisher's exact test was applied for categorical data. Logistic regression and chi-square were used for comparisons between the 2 diagnosis and between the 2 treatments. Spearman's correlation coefficient was used to test the relation between treatment and the different instruments. The level of significance was set at P < 0.05.
| Ethical approval
The Regional Ethics Committee of Uppsala, Sweden approved the study and all participating couples gave oral and written informed consent (2012/306).
| RE SULTS

| Patient characteristics
Initially, 198 women were asked to answer the questionnaires and 102 women (51.5%) were included in the study divided into 2 groups, spontaneous miscarriage (n = 35) and missed miscarriage (n = 67) ( Figure 1 ).
Four months after the miscarriage, 77% (27 of 35) of the women in the spontaneous miscarriage group and 80% (54 of 67) of the women in the missed miscarriage group answered the questionnaire again.
There was no difference in age, body mass index, week of miscarriage, or previous number of children or planned pregnancy F I G U R E 1 Number of participants, women with miscarriage, and drop outs. The reasons for medical dropout were recurrent pregnancy loss and pregnancy complications such as extrauterine pregnancy or molar pregnancy
Women with miscarriage who were asked to participate in the study n = 198
Excluded for medical reasons n = 24
Did not answer n = 63
Declined inclusion in the study n = 9
Agreed to participate n = 174
Included in the study n = 102
Missed miscarriage n = 67
Spontaneous miscarriage Spontaneous miscarriage n = 35
Missed miscarriage n = 54 n = 27
Did not answer n = 8
Did not answer n = 13 
| Experience of miscarriage (RIMS)
One week after the miscarriage, there was no difference in the 3 experienced factors included in the RIMS scale between women who had a missed miscarriage and women who had a spontaneous miscarriage ( Table 2 ). Four months after the miscarriage, experience of "Isolation/guilt" was reduced both in women with spontaneous miscarriage and women with missed miscarriage (Table 3) .
Further, the RIMS factor "Loss of baby" was reduced in women with missed miscarriage, but it remained the same in women with spontaneous miscarriage (Table 3) . "Devastating event" was also reduced although this did not reach statistical significance.
None of the three factors, "Isolation/Guilt," "Loss of baby," and "Devastating event" correlated with the duration of treatment, r = .006, P = 0.548, r = .146, P = 0.143, and r = .057, P = 0.567, respectively.
| Depressive symptoms (MADRS-S)
Women with spontaneous miscarriage and women with missed miscarriage had similar scores 1 week after treatment as measured using MADRS-S (Table 2 ). After 4 months the MADRS-S score was significantly reduced in both patient groups (Table 3 ). There was no correlation between duration of treatment and MADRS score, r = .111, P = 0.269.
| Perinatal Grief Scale
Scores from PGS were similar in both groups, 1 week after miscarriage ( Table 2 ). "Grief" and "Coping," but not "Despair,"
were significantly reduced with time 4 months after the miscarriage (Table 3 ). There was no correlation between duration of treatment and "Grief," r = .0886, P = 0.380. "Despair," r = .141, Data are given as median and range or n (%). Chi-squared test and multiple regression analysis were performed. Statistical significance is shown: * P < 0.05 and ** P < 0.01.
TA B L E 2
Treatment data of women with spontaneous miscarriage and women with missed miscarriage P = 0.160 between women with spontaneous miscarriage and missed miscarriage. However, there was a correlation between "Coping" and duration of treatment, r = .214, P = 0.0326 between the two groups.
| Diagnosis and treatment
Longer duration of treatment and more frequent additional treatment, usually vacuum aspiration or mifepristone, were seen in women with missed miscarriage (Table 2) .
Women receiving additional treatment after misoprostol alone had significantly more visits to the hospital whereas those who received misoprostol alone had higher score on depressive symptoms (Table 4 ).
| D ISCUSS I ON
One week after the miscarriage, there was no difference between the two diagnosis groups of miscarriages on the experiences as measured by use of RIMS, MADRS, or PGS. Feelings of "Isolation/ guilt," as measured by RIMS, were significantly reduced 4 months after treatment. The other factors were also reduced, although only significantly for "Loss of baby" in the missed miscarriage group, TA B L E 3 Scores from three questionnaires Revised Impact of Miscarriage Scale (RIMS), Montgomery and Åsberg Depression Rating Scale (MADRS) and Perinatal Grief Scale (PGS) in women after spontaneous miscarriage (n = 27 of 35, 77%) and missed miscarriage (n = 54 of 67, 80%) Statistical calculations was performed according to Mann-Whitney U test, data are given as median and range. Statistical significance is shown: * P < 0.05, ** P < 0.01 and *** P < 0.001.
TA B L E 4 Data from 3 questionnaires
Revised Impact of Miscarriage Scale (RIMS), Montgomery and Åsberg Depression Rating Scale (MADRS) and Perinatal Grief Scale (PGS) in women with miscarriage treated with misoprostol alone (n = 51) or with vacuum aspiration subsequent to the misoprostol treatment (n = 24) 1 week after completion of the miscarriage suggesting that the experiences after miscarriage were reduced with time, regardless of diagnosis of miscarriage. This contrasts with a previous study, where there were no differences in any of the RIMS factors after 4 months, 15 and it was speculated that longer time was needed to recover from a miscarriage. The reason for the discrepancy could be cultural differences, despite our previous study showing that the experiences after miscarriage were similar in Swedish and American couples after 1 week, but comparisons on the longitudinal level were lacking. 10 In a recent prospective study, the number of women with miscarriage or ectopic pregnancy showing moderate to high depression according to MADRS-S scores was around 15% and decreased after 3 months. 16 This was also the case in the present study, where 14%
of women with spontaneous miscarriage and 16% of women with missed miscarriage showed moderate to severe depressive symptoms. The depressive symptoms were significantly reduced after 4 months in both patient groups, which is in contrast to the study of women with ectopic pregnancy, where the post-traumatic stress syndrome persisted for at least 3 months. 16 For the PGS factor, "Grief," there was no difference between women with spontaneous miscarriage and women with missed miscarriage. The grief was significantly reduced after 4 months in both groups, regardless of duration or type of treatment. The reduction in grief with time has also been noted previously, 17 as it was shown that grief after miscarriage is associated with pregnancy-specific anxiety, depression symptoms, post-traumatic stress, and intimate partnerrelationship. 12 However, psychological counseling could aid women to reduce grief, self-blame, and worries after missed miscarriage, 18 and a structured psychological monitoring could reduce grief after miscarriage.
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Treatment options were chosen after a shared discussion between the doctor and the patient, and usually followed the tradition in the clinic. The patients are in a stressful situation, and would probably need more knowledge and understanding about different treatment alternatives than they receive before making a decision. 20 However, it is difficult to comprehend too much information in a stressful situation. It has previously been shown that the most important factors for the patients' decision-making are the probability of a successful treatment and the risk of reduced fertility. 21 When women having a second miscarriage have a choice of treatment, expectant vs surgical, more than 80% would chose the same treatment again.
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In cases where the intended effect of misoprostol alone is lacking, treatment with mifepristone or vacuum aspiration is introduced in Sweden for completion of the miscarriage. 23 Women treated with misoprostol alone had significantly higher MADRS-S scores than women treated with misoprostol and subsequent vacuum aspiration.
This could be because the longer treatment time with misoprostol alone makes the depressive symptoms more pronounced.
In the present study, the misoprostol alone alternative seems to be less efficient for women with missed miscarriage as 31.5%
received the combined treatment of misoprostol and vacuum aspiration whereas only 8.5% women in the spontaneous miscarriage group had the combined treatment. Coping scores correlated with duration of treatment, and as vacuum aspiration is a faster option, this increased the ability to cope after the miscarriage. Therefore, it could be recommended to use vacuum aspiration as early as possible during treatment of missed miscarriage to aid coping strategies.
However, the adverse effects of the different treatments have to be considered. Vacuum aspiration includes a small risk of cervical tears and uterine perforation after induced abortion 24 whereas mifepristone treatment is more efficient than misoprostol alone, 25 but there is also a risk of excessive bleeding that might require hospital care. 26 Most women included in the study had planned their pregnancy, 88.6% of women with spontaneous miscarriage and 97.0% of women with missed miscarriage, with no significant differences between the groups. This is in agreement with previous Swedish studies, showing that > 75% of pregnancies in Sweden are planned. 27 In a recent cross-sectional study from the USA it was shown that unplanned pregnancies more often resulted in spontaneous miscarriage.
However, the cause of miscarriage was not included in the American study where the percentage of planned pregnancies is 44.5%, which is considerably lower than in the present study. 28 Therefore, as most of the pregnancies were planned, it is not likely that unwanted pregnancies influence the occurrence of miscarriage in the present study.
One limitation of the study was the low response rate (63.6%), after exclusion for medical reasons (recurrent pregnancy loss and pregnancy complications such as extrauterine pregnancy or molar pregnancy) and lack of language skills, 51.5% remained. However, a sample size calculation was performed before initiation of the study based on data from a previous study, 15 assuming a difference in score on one of the RIMS factors of 3 ± 5, an α value of 0.05 and a desired power of 0.8, a sample size of 45 is sufficient. In the present study, we included 102, which would be enough.
The distribution between the different diagnoses was not equal.
Women with complete spontaneous abortion might call the clinic and be advised to stay at home or they do not have a follow-up visit to the clinic and are therefore not asked for inclusion in the study.
Further, when these women come to the clinic, they might have less emotional stress and therefore less interest in being included in a study on psychological well-being after miscarriage. This might bias the result and so there is a risk of type 1 or type 2 errors; a higher number of study participants would probably have improved the data. 29 The study was designed to include all women with miscarriage according to the Swedish regulation and WHO criteria as expulsion of an embryo or extraction of a fetus weighing 500 g or less before week 22 of gestation. Therefore, we did not exclude second-trimester miscarriage. We have calculated the data both with and without the three women included in the study who had a second-trimester miscarriage, and the results remain the same.
The present study is a prospective cohort study, the women were asked 1 week after and 4 months after the treatment was finalized.
For practical reasons, it is not possible to ask the women to be included in the study before the miscarriage, as a miscarriage cannot be foreseen. For ethical reasons, it is not best to ask women to participate at their first visit to the doctor, because in most cases they are in a state of shock. For this reason, we chose to ask the women to be included after the treatment was completed. Therefore, the actual treatment had already been decided on by the doctor and the patient after discussion of treatment options. However, it is still possible that the treatment influences the response to the questionnaires.
A strength of the study is that the cultural origin of the women is the same as would be expected in the general population, and we assume that the results are valid for Swedish conditions. This is in line with our previous study, where we show that experiences of miscarriage are the same regardless of cultural differences. 10 Another strength of the study is that the three questionnaires have been used in several previous studies, that MADRS-S was developed for Swedish conditions and the other two scales have been validated for Swedish conditions. 10, 30 One more strength was that most women, 77% and 80% respectively, answered the second questionnaire.
| CON CLUS ION
In the present study it was shown that the type of treatment rather than the diagnosis of miscarriage might determine emotional feelings after a miscarriage. Women treated with misoprostol and subsequent vacuum aspiration had shorter duration of treatment and improved emotional health related to isolation, grief, coping, and despair than women treated with misoprostol alone. Therefore, we suggest that it might be an advantage if treatment of miscarriage strive for treatment to be as efficient and of as short a duration as possible.
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